Cambridge Investment Research Advisors’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-64
| Closed | -$13K | – | 3320 |
|
|
2023
Q1 | $13K | Sell |
64
-2
| -3% | -$406 | ﹤0.01% | 3126 |
|
|
2022
Q4 | $10K | Sell |
66
-1
| -1% | -$152 | ﹤0.01% | 3079 |
|
|
2022
Q3 | $20K | Hold |
67
| – | – | ﹤0.01% | 3002 |
|
|
2022
Q2 | $28K | Sell |
67
-2
| -3% | -$836 | ﹤0.01% | 2980 |
|
|
2022
Q1 | $38K | Sell |
69
-2
| -3% | -$1.1K | ﹤0.01% | 3096 |
|
|
2021
Q4 | $61K | Sell |
71
-7
| -9% | -$6.01K | ﹤0.01% | 3084 |
|
|
2021
Q3 | $93K | Buy |
+78
| New | +$93K | ﹤0.01% | 2966 |
|